Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors
about
Hostile takeovers: viral appropriation of the NF-kB pathwayEssential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcriptionTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationComplex genetic predisposition in adult and juvenile rheumatoid arthritisPotent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivativesDiazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cellsHost-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat siteProperties of non-coding DNA and identification of putative cis-regulatory elements in Theileria parvaRegulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.Variability in drug metabolizing enzyme activity in HIV-infected patients.Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-κappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cellsStromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophagesPhagocytic function of monocytes in children with human immunodeficiency virus type 1 infection.EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulenceThe ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells.Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.Interplay of Rad51 with NF-κB pathway stimulates expression of HIV-1.RETRACTED: MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses.Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages.Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradationInduction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR.Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages.Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter.Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFκΒ signaling by stabilizing IκBα.IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancerInhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis.Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.Molecular and pathologic insights from latent HIV-1 infection in the human brainThe nfkb1 promoter is controlled by proteins of the Ets family.HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter.Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages.
P2860
Q22241900-3C24E373-A2F0-4285-BF09-905B949AFA9EQ24530567-920C70BB-78EE-47E6-A691-FAB080058BBEQ24681560-28588CA3-3EF9-45D4-A647-0784E4064F23Q24798945-649071F7-0E37-43B7-AABE-3A65D43A4857Q28378960-9B24A4FF-D75A-4CFD-BD35-F8ACB520DA37Q28379229-8A3F68BF-CB85-4FE4-8153-F4CA3621E064Q28386446-D608397B-1FC9-403F-81C0-F31901DB34B9Q30480091-398EEF9B-05B3-4FB5-A94E-EC4189FC3D89Q33266806-EF89A8DB-BE03-4E13-A8E4-9FB0E2E989CDQ33389555-868C32A9-3C3D-4494-82B5-74E782A6EE88Q33587139-186E1866-2A45-4287-A5FD-51CB6C2997F6Q33613718-6A94DE98-AAFF-489D-99AE-F687D21E9335Q33791508-64E4C512-8676-40C0-B8AF-544CBC31FFA3Q33800452-F00548EB-D3AC-40F5-B200-3A450BFE2D35Q33921277-FE1F08BC-64EE-40BB-B16F-6CEDDFC848E6Q33998274-D620B395-E8BF-4FFC-B2BF-75B5A81DCE0FQ34047542-34D3B438-57F0-4390-83FD-6DB9658972A8Q34271313-BF86D5FF-CE68-4A50-BD10-6FE552F1A551Q34350420-E522BBC2-F8D5-4399-9E78-B51D1AE4C369Q34352092-95F41253-11FF-4D1F-9BA2-BBCA723B43CAQ34720640-7ADA9ACC-1267-4978-AF84-B9E4D9B9C240Q35024097-BB1C501B-CF5E-4E91-951F-F2D7B3D97360Q35171923-38E88E7B-B643-4D09-B631-E7907C485BE3Q35343462-818CDF23-6AAD-41F0-9C35-5FE4A4F0920BQ35519550-26F28E52-4FC4-4B9D-B47D-9952850F8330Q35823900-0866F7C8-55EA-49D9-88A1-6A6E5232399FQ35865967-06D9A98A-085C-48C4-9F6D-5F8CA29B53E8Q35877650-0880E69E-FBE2-4B40-B9B3-9CA575627096Q35878462-D293A0AD-7846-4BFD-9B21-D4E6CB29CCF3Q35956508-DBB9F6FA-C19F-4CCF-AB9C-52057F67C11AQ36267881-2398A9A0-A301-4B52-8F39-3FFBA807E8B5Q36498248-7DF733E8-4519-411E-B4E8-A122AB991EB4Q36672118-57FFC696-0B06-4FF2-9434-E3F273D737BAQ36706005-957DC62D-3127-4350-A736-2A0E9252DBA7Q36869931-1DB22B1A-0149-47A6-850C-F0BEE26EE920Q37384802-13B881A2-AE22-4AE9-951E-B6D3162DA86FQ37720509-5FF83057-3660-4313-83A1-864E5A7065E5Q38321481-DFA9E805-2B70-451C-9F3A-F6BEA0B1294DQ38358557-6AD20FBE-22E1-4133-ADB3-1FAC8A9ED821Q39683481-B43E4EF7-1AD2-4639-B746-C7563340DC1F
P2860
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Regulation of human immunodefi ...... pa B/Rel transcription factors
@ast
Regulation of human immunodefi ...... pa B/Rel transcription factors
@en
Regulation of human immunodefi ...... pa B/Rel transcription factors
@nl
type
label
Regulation of human immunodefi ...... pa B/Rel transcription factors
@ast
Regulation of human immunodefi ...... pa B/Rel transcription factors
@en
Regulation of human immunodefi ...... pa B/Rel transcription factors
@nl
prefLabel
Regulation of human immunodefi ...... pa B/Rel transcription factors
@ast
Regulation of human immunodefi ...... pa B/Rel transcription factors
@en
Regulation of human immunodefi ...... pa B/Rel transcription factors
@nl
P2093
P2860
P1476
Regulation of human immunodefi ...... pa B/Rel transcription factors
@en
P2093
A Roulston
M A Wainberg
P Beauparlant
P2860
P304
P407
P577
1995-09-01T00:00:00Z